These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24689529)

  • 1. The promise and limitations of TNF-α inhibition for uveitis.
    Cunningham ET; Zierhut M
    Ocul Immunol Inflamm; 2014 Apr; 22(2):87-9. PubMed ID: 24689529
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.
    Mangge H; Heinzl B; Grubbauer HM; El-Shabrawi Y; Schauenstein K
    Rheumatol Int; 2003 Sep; 23(5):258-61. PubMed ID: 12687288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient.
    Tsang AC; Roth J; Gottlieb C
    Ocul Immunol Inflamm; 2014 Apr; 22(2):155-7. PubMed ID: 24377416
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab for juvenile idiopathic arthritis-associated uveitis.
    Richards JC; Tay-Kearney ML; Murray K; Manners P
    Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab in the therapy of uveitis in childhood.
    Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
    Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
    Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
    J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
    Tappeiner C; Heinz C; Ganser G; Heiligenhaus A
    J Rheumatol; 2012 Jun; 39(6):1294-5. PubMed ID: 22661419
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
    Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
    Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
    Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
    J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of uveitis after discontinuation of infliximab.
    Shakoor A; Esterberg E; Acharya NR
    Ocul Immunol Inflamm; 2014 Apr; 22(2):96-101. PubMed ID: 23876234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
    Palmou-Fontana N; Calvo-Río V; Martín-Varillas JL; Fernández-Díaz C; Mesquida M; Adán A; Hernández MV; Cordero-Coma M; Maiz Alonso O; Díaz-Valle D; Fernández-Cid C; Ruiz-Moreno O; Hernández JL; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2018; 36(4):652-657. PubMed ID: 29303704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golimumab for uveitis.
    Cordero-Coma M; Salom D; Díaz-Llopis M; López-Prats MJ; Calleja S
    Ophthalmology; 2011 Sep; 118(9):1892.e3-4. PubMed ID: 21889663
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy.
    Lim LT; Ruzmetova N; Ballinger SH; Moorthy RS
    Int Ophthalmol; 2011 Aug; 31(4):349-51. PubMed ID: 21842402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors.
    Lerman MA; Lewen MD; Kempen JH; Mills MD
    Am J Ophthalmol; 2015 Jul; 160(1):193-200.e1. PubMed ID: 25892124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ; Dick AD; Lee RJ; Ramanan AV; Carreño E; Guly CM; Ross AH
    Surv Ophthalmol; 2016; 61(2):197-210. PubMed ID: 26599495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research update of anti-TNF-α biologic agents in the treatment of uveitis].
    Fan F; Zhou M; Luo Y
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):285-8. PubMed ID: 23866712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab and adalimumab for uveitis.
    Martel JN; Esterberg E; Nagpal A; Acharya NR
    Ocul Immunol Inflamm; 2012 Feb; 20(1):18-26. PubMed ID: 22324897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.